Learning from Innovation in the Health Industry
Edited by Marco R. Di Tommaso and Stuart O. Schweitzer
Chapter 10: Spillovers of University–High-Tech Industry Alliances
Werner Z. Hirsch INTRODUCTION In line with the notion of spillovers incorporated in the Health Industry Model of Di Tommaso and Schweitzer (2001), this chapter explores this phenomenon in regard to a rather novel form of collaboration between research universities and high-tech industries. It will point to the beneﬁts that are expected to ﬂow from research alliances, a major reason why these have become increasingly common. Modelling of the spillover process will come next, along with an analysis of the regional clustering process, to be followed by a case study of the spillover process. Finally, some important further research needed in this area is explored. To be a player in the knowledge-based high-tech economy, often looked upon as a key element in the ‘new economy’, requires successful and timely innovation and product inventions for which there will be a responsive demand. In contrast to the ‘old economy’, the high-tech industries of the new economy, especially pharmaceuticals, semiconductors and computer software, incur extremely high development and start-up costs, inordinately low production costs and yet exceptionally rapid obsolescence. While, thus, high-tech companies have a strong incentive to collaborate with research universities, so have the universities to collaborate with industry. These mutual interests have given impetus to the formation of new forms of university–high-tech industry collaboration, with research alliances being perhaps the most prominent. However, such collaboration not only beneﬁts a speciﬁc university and ﬁrm, but provides spillovers to other universities and ﬁrms as well as to the economy...
You are not authenticated to view the full text of this chapter or article.